Avagliano Mark Insider Trades

Insider Trading History

Track insider trading activity for Avagliano Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $1.88M 262,645 shares
Last Trade
Sep 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 20,600 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $186k 26,035 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.63M 367,110 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$186k 26,035 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $1.73M 242,045 shares
Last Trade
Jul 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.62k 2,638 shares
$2.51
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $1.75M 244,683 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.5k 35,000 shares
$2.47
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $1.5M 209,683 shares
Last Trade
May 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$39k 8,151 shares
$4.79
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $1.56M 217,834 shares
Last Trade
Mar 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 100,000 shares
$3.45
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $844k 117,834 shares
Last Trade
Jan 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.12k 721 shares
$2.94
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $867k 121,157 shares
Last Trade
Jan 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.5k 3,360 shares
$3.12
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $873k 121,915 shares
Last Trade
Jan 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266k 89,400 shares
$2.97
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $552k 77,155 shares
Last Trade
May 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 35,000 shares
$2.92
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $154k 21,555 shares
Last Trade
Jan 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.3k 1,445 shares
$10.61
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $379k 53,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$567k 53,000 shares
$10.69
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $415k 58,000 shares
Last Trade
Jan 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 58,000 shares
$18.07
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $430k 60,000 shares
Last Trade
Feb 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 60,000 shares
$21.08
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Chief Business Officer
Holding Value $2.15M 300,000 shares
Last Trade
Jul 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.72M 300,000 shares
$25.72
$7.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up